These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12724127)

  • 1. Human pulmonary chimerism after hematopoietic stem cell transplantation.
    Suratt BT; Cool CD; Serls AE; Chen L; Varella-Garcia M; Shpall EJ; Brown KK; Worthen GS
    Am J Respir Crit Care Med; 2003 Aug; 168(3):318-22. PubMed ID: 12724127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study].
    Thiele J; Varus E; Wickenhauser C; Kvasnicka HM; Metz K; Schaefer UW; Beelen DW
    Pathologe; 2002 Nov; 23(6):405-10. PubMed ID: 12436292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipients.
    Zander DS; Cogle CR; Theise ND; Crawford JM
    Ann Clin Lab Sci; 2006; 36(1):47-52. PubMed ID: 16501236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
    del Cañizo C; Lopez N; Caballero D; Fernandez E; Brufau A; Vazquez L; Mateos V; Gutierrez N; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(9):901-5. PubMed ID: 10338045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary endothelial chimerism after hematopoietic stem cell transplantation.
    Hijiya K; Chen-Yoshikawa TF; Miyagawa-Hayashino A; Kondo T; Aoyama A; Haga H; Takaori-Kondo A; Date H
    Surg Today; 2018 Jan; 48(1):101-109. PubMed ID: 28689269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
    Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
    Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
    Körbling M; Katz RL; Khanna A; Ruifrok AC; Rondon G; Albitar M; Champlin RE; Estrov Z
    N Engl J Med; 2002 Mar; 346(10):738-46. PubMed ID: 11882729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation.
    Mattsson J; Jansson M; Wernerson A; Hassan M
    Transplantation; 2004 Jul; 78(1):154-7. PubMed ID: 15257055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.
    Mueller RJ; Stussi G; Puga Yung G; Nikolic M; Soldini D; Halter J; Meyer-Monard S; Gratwohl A; Passweg JR; Odermatt B; Schanz U; Biedermann BC; Seebach JD
    Haematologica; 2011 Jan; 96(1):119-27. PubMed ID: 20934999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial tissue chimerism after human hematopoietic cell transplantation is a real phenomenon.
    Spyridonidis A; Schmitt-Gräff A; Tomann T; Dwenger A; Follo M; Behringer D; Finke J
    Am J Pathol; 2004 Apr; 164(4):1147-55. PubMed ID: 15039204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
    Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
    Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
    J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of chimerism analysis to allogeneic hematopoietic stem cell transplantation by STR-PCR].
    Sun JF; Han XP; Zhao DD; Wang FF; Jin HJ; Gao CJ; DA WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):337-41. PubMed ID: 17493343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.